Crying over spilt milk here but if only we had not had those initial delays with the phase 1 MND trials. We could potentially be well on our way with our own phase 2/3 trial and likely making the Relyvrio trial results redundant anyway. A 40% chance of success for Relyvrio doesn't sound very good now does it?
PharmAust media thread, page-212
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.010(4.65%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 20.5¢ | $113.4K | 540.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2623 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
20.5¢ |
Change
-0.010 ( 4.21 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 21.5¢ | 20.5¢ | 318787 | ||
| Last updated 15.38pm 04/06/2024 ? | |||||
| PAA (ASX) Chart |